Market Cap: $9.18B
CI
Cytokinetics, Incorporated
CYTK
NASDAQUSD
Market Cap: $9.18B
Analysts estimated CYTK earnings of $-1.67 per share this quarter (Q2). CYTK's actual earnings were $-1.50 per share.
CYTK EPS surprise of 10.35%Analysts estimated CYTK earnings of $-1.61 per share this quarter (Q3). CYTK's actual earnings were $-2.55 per share.
CYTK EPS surprise of -58.24%Analysts estimated CYTK earnings of $-1.41 per share this quarter (Q2). CYTK's actual earnings were $-1.12 per share.
CYTK EPS surprise of 20.28%Analysts estimated CYTK earnings of $-1.27 per share this quarter (Q3). CYTK's actual earnings were $-1.36 per share.
CYTK EPS surprise of -6.82%Analysts estimated CYTK earnings of $-1.08 per share this quarter (Q2). CYTK's actual earnings were $-1.31 per share.
CYTK EPS surprise of -21.59%Analysts estimated CYTK earnings of $-1.16 per share this quarter (Q1). CYTK's actual earnings were $-1.33 per share.
CYTK EPS surprise of -14.18%Analysts estimated CYTK earnings of $-0.99 per share this quarter (Q4). CYTK's actual earnings were $-1.38 per share.
CYTK EPS surprise of 39.39%